| 301 |
percutaneous collagen induction using dermaroller versus 80% trichloroacetic acid in the treatment of atrophic post acne scars: a comparative study. |
2015 |
| 302 |
Pharmacologic screens reveal metformin that suppresses GRP78-dependent autophagy to enhance the anti-myeloma effect of bortezomib |
2015 |
| 303 |
Risk genes and autoantibodies in Egyptian children with type 1 diabetes – low frequency of autoantibodies in carriers of the HLA-DRB1*04:05-DQA1*03-DQB1*02 risk haplotype. |
2015 |
| 304 |
serum leptin and insulin resistance in non alcholic fatty liver disease |
2015 |
| 305 |
Serum miRNA-1 as a novel biomarker for acute myocardial infarction and unstable angina |
2015 |
| 306 |
Significance of Urinary Neutrophil Gelatinase-Associated Lipocalin Detection in Patients with Lupus Nephritis |
2015 |
| 307 |
SUBCLINICAL RENAL AFFECTION IN PATIENTS WITH Β-THALASSEMIA MAJOR: IN RELATION TO CHELATION THERAPY VERSUS BLOOD TRANSFUSION THERAPY |
2015 |
| 308 |
SUBCLINICAL RENAL AFFECTION IN PATIENTS WITH Β-THALASSEMIA MAJOR: IN RELATION TO CHELATION THERAPY VERSUS BLOOD TRANSFUSION THERAPY. |
2015 |
| 309 |
Systems-based pharmacogenomics reveals that the ubiquitin ligase SCF-SKP2 is a molecular determinant of clinical response to bortezomib-based therapy |
2015 |
| 310 |
Targeting the ubiquitin ligase SKP2 in the myeloma stem-cell like side population. |
2015 |
Do you have any questions? 
